VERTEX PHARMACEUTICALS INC (VRTX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VRTX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VRTX | Chief Financial Officer and Executive Vice President, Zimmer Biomet; Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain | 57 | ["Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain of Zimmer Biomet since July 2019", "Senior Vice President, Global Financial Operations at Bristol-Myers Squibb from 2016 to June 2019", "Executive Vice President and Chief Financial Officer of Endo International from 2013 to 2016", "Interim Chief Financial Officer and Senior Vice President of Finance, Corporate Controller and Principal Accounting Officer of Becton Dickinson", "Senior Vice President of Global Financial Planning and Analysis and Vice President and Chief Financial Officer of Becton Dickinson\u2019s international business", "Held a number of global finance and strategy roles across AstraZeneca and Johnson & Johnson", "Spent the early part of his career in public accounting with KPMG", "Holds a Bachelor of Science in Finance from Albright College and an MBA from The Fuqua School of Business at Duke University"] | ["Audit and Finance Committee", "Management Development and Compensation Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ZBH | Executive Vice President and CFO | [] | [] | 2020 |
Biography sourced from the proxy statement filing.
Age: 57 Director Since: 2022 Board Committees: Chair Audit and Finance Committee Member Management Development and Compensation Committee Experience: Other Public Company Boards: None Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain of Zimmer Biomet, a leading global innovator and manufacturer of orthopedic solutions, since July 2019 Senior Vice President, Global Financial Operations at Bristol-Myers Squibb from 2016 to June 2019 Executive Vice President and Chief Financial Officer of Endo International from 2013 to 2016 Previously served as interim Chief Financial Officer and Senior Vice President of Finance, Corporate Controller and Principal Accounting Officer of Becton Dickinson, and Senior Vice President of Global Financial Planning and Analysis and Vice President and Chief Financial Officer of Becton Dickinson s international business Previously held a number of global finance and strategy roles across AstraZeneca and Johnson & Johnson, including Research and Development, Supply Chain, Commercial Operations and Business Development Spent the early part of his career in public accounting with KPMG, earning his CPA designation and his CMA designation (each designation currently inactive) Holds a Bachelor of Science in Finance from Albright College and an MBA from The Fuqua School of Business at Duke University Key Skills and Qualifications: Mr. Upadhyay has extensive experience in the health care industry in financial roles covering all major areas of a fully integrated life sciences business. His service as an executive in the pharmaceutical, hospital supply, and medical device industries provide him with multiple perspectives on our industry. His knowledge and expertise make him a valuable contributor to our board of directors and management.